Skip to main content
TipRanks
Go Ultimate75% OFF

SecuAvail, Inc. (3042) AI Stock Analysis

0 Followers
JP:3042

SecuAvail, Inc.

(TSE/TYO:3042)

Select Model
Rating:59Neutral
Price Target:JPY 788.00â–²(7.07% Upside)
Action:reiterated
Date:11/13/26

The score is held up by a very strong, low-leverage balance sheet and improved 2026 profitability, but capped by weak multi-year earnings/cash-flow consistency and very poor valuation (P/E ~248.8). Technicals are mixed, with longer-term trend support but near-term softness.

Positive Factors
Very low leverageExtremely low leverage gives the company a substantial solvency buffer and reduces dependence on creditors. The strong equity base can support operations and selective investment while limiting the interest burden that would otherwise pressure earnings and financial flexibility.
Negative Factors
Volatile earnings historyWide swings in profitability make the latest earnings level less dependable as a measure of recurring performance. This volatility complicates planning, reduces confidence in near-term earnings durability, and can limit the company’s ability to commit consistently to investment or shareholder returns.

SecuAvail, Inc. (3042) vs. iShares MSCI Japan ETF (EWJ)

-100%0%100%200%300%400%JP:3042+112.76%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 5.66B
Dividend Yield
0.66%
Average Volume (3M)
2.76M
Price to Earnings (P/E)
242.9
Beta (1Y)
0.69
Revenue Growth
-0.89%
EPS Growth
-77.64%
Country
Japan
Employees
116
Sector
Technology
Sector Strength
61
Industry
Software - Infrastructure

SecuAvail, Inc. Business Overview & Revenue Model

Company Description

SecuAvail Inc., headquartered in Osaka, Japan, and founded in 2001, delivers extensive cybersecurity solutions across Japan. The company operates through two primary divisions: Information Security and Human Resource Services. Within its information...

SecuAvail, Inc. Financial Statement Overview

Summary

Financials are mixed. The balance sheet is a major strength with extremely low leverage (debt-to-equity ~0.6%) and solid equity backing assets, and profitability rebounded in 2026 with improving margins. However, earnings have been volatile (loss-making EBIT in 2022–2023 and an unusual 2024 profit), and cash conversion remains weak despite 2026 improvement (operating cash flow ~0.14x net income).

Income Statement

66Positive

Balance Sheet

88Very Positive

Cash Flow

48Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2026Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue1.24B1.15B1.28B1.10B1.03B957.04M
Gross Profit531.12M450.75M580.47M443.09M412.58M371.57M
EBITDA114.49M36.05M116.99M-18.29M-19.43M-72.83M
Net Income104.41M42.81M105.72M228.96M-44.04M-111.83M
Balance Sheet
Total Assets1.51B1.55B1.58B1.48B1.33B1.36B
Cash, Cash Equivalents and Short-Term Investments1.14B1.11B1.13B1.20B769.49M811.06M
Total Debt1.75M2.27M7.79M4.32M6.29M0
Total Liabilities309.74M367.68M297.42M337.30M265.33M253.35M
Stockholders Equity1.20B1.19B1.28B1.15B1.06B1.11B
Cash Flow
Free Cash Flow0-26.99M35.75M-41.29M-45.46M-156.42M
Operating Cash Flow0-20.06M38.75M-25.93M-41.21M-151.49M
Investing Cash Flow0-66.37M-2.65M459.15M3.72M1.52M
Financing Cash Flow0-2.05M-17.40M-1.97M-4.08M-19.08M

SecuAvail, Inc. Technical Analysis

Technical Analysis SentimentPositive
Last Price736.00

Price Trends

50DMA636.00Positive
100DMA464.07Positive
200DMA385.74Positive

Market Momentum

MACD42.37Positive
RSI45.25Neutral
STOCH12.11Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3042, the sentiment is Positive. The current price of 736.00 is below the 20-day moving average (MA) of 1028.85, above the 50-day MA of 636.00, and above the 200-day MA of 385.74, indicating a neutral trend. The MACD of 42.37 indicates Positive momentum. The RSI at 45.25 is Neutral, neither overbought nor oversold. The STOCH value of 12.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3042.

SecuAvail, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:3042 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4475JP:447583OutperformJPY 81.23B41.66―0.46%17.01%34.74%
JP:3040JP:304079OutperformJPY 48.23B15.5123.79%2.23%13.07%28.70%
JP:3694JP:369478OutperformJPY 24.15B20.41――21.05%-2.47%
JP:4417JP:441772OutperformJPY 129.67B58.50―0.51%25.18%85.59%
JP:4493JP:449368NeutralJPY 22.15B23.96―0.22%22.65%74.18%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
JP:3042JP:304259NeutralJPY 5.80B242.90―0.66%-0.89%-77.64%

* Technology Sector Average

Performance Comparison

0%100%200%300%400%JP:3042JP:3040JP:3694JP:4417JP:4475JP:4493Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:3042 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3042SecuAvail, Inc.736.00409.73125.58%
JP:3040Soliton Systems KK2600.00845.0948.16%
JP:3694OPTiM Corp.431.00-127.00-22.76%
JP:4417Global Security Experts Inc.8470.004928.52139.17%
JP:4475HENNGE K.K.2378.001039.5577.67%
JP:4493Cyber Security Cloud, Inc.2244.00256.5012.91%

SecuAvail, Inc. Corporate Events

SecuAvail Reports Increased Cybersecurity Interest Since October

Nov 13, 2026

Since October 2026, SecuAvail has reported increased cybersecurity interest in Japan and overseas, with corporate and organizational inquiries trending upward. Awareness of cybersecurity needs has also risen among large enterprises and medium-sized a...

SecuAvail Reports Six-Month Sales Decline, Losses

Nov 13, 2026

SecuAvail Inc., listed on the Tokyo Stock Exchange and Sapporo Securities Exchange, reported consolidated results for the six months ended September 30, 2026. Sales fell 8.2% year on year to ¥584 million.The company recorded an operating loss of ¥23...

SecuAvail Nears Cap on Share Buyback, Signaling Focus on Shareholder Returns

Oct 6, 2026

SecuAvail Inc. has completed a share repurchase program authorized by its board in mid-August, buying back 196,000 common shares between October 1 and October 5 via market purchases on the Tokyo Stock Exchange. The latest tranche cost approximately ¥...

SecuAvail Advances Share Buyback Under ¥100 Million Repurchase Plan

Oct 2, 2026

SecuAvail Inc. has disclosed the progress of a share repurchase program authorized by its board on August 14, 2026, under provisions of the Companies Act and its Articles of Incorporation. Between September 1 and September 30, 2026, the company bough...

SecuAvail Starts Share Buyback Under ¥100 Million Repurchase Plan

Sep 4, 2026

SecuAvail Inc. has begun executing a previously approved share repurchase program, acquiring 53,100 shares of common stock on the Tokyo Stock Exchange between August 17 and August 31, 2026 for a total of ¥15,897,400. This initial tranche is part of a...

SecuAvail Swings to Q1 Loss as Large Software Deals Slow but Expects Year-End Rebound

Aug 14, 2026

SecuAvail reported first-quarter FY2027 consolidated net sales of ¥260.5 million, a 17.5% year-on-year decline, primarily because no large-scale software project was booked, although recurring stock-type service revenue held steady. The company poste...

SecuAvail Launches Share Buyback to Bolster Capital Efficiency

Aug 14, 2026

SecuAvail Inc. has approved a share buyback program, resolving to acquire up to 400,000 shares of its common stock, representing about 5.2 percent of its outstanding shares excluding treasury stock. The purchases, capped at 100 million yen, will be c...

SecuAvail Posts Quarterly Loss but Expects Full-Year Recovery

Aug 14, 2026

SecuAvail Inc. reported a weak start to its fiscal year ending March 31, 2027, posting a 17.5% year-on-year decline in net sales to ¥260 million for the three months ended June 30, 2026. The company swung to an operating loss of ¥52 million and a net...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026